Psychiatry Investigation

Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study: Seung-Hoon Lee, Sang Won Jeon, Cheolmin Shin, Chi-Un Pae, Ashwin A. Patkar, Prakash S. Masand, Hyonggin An, Changsu Han; Psychiatry Investig. 2022;19(4):268-280. Published online April 22, 2022; DOI: https://doi.org/10.30773/pi.2021.0368
Web of Science 4 Crossref 5; Full text PubReader ePub PDF Supplementary Materials

Efficacy of Buspirone Augmentation of Escitalopram in Patients with Major Depressive Disorder with and without Atypical Features: A Randomized, 8 Week, Multicenter, Open-Label Clinical Trial: Cheolmin Shin, Young-Hoon Ko, Se-Hoon Shim, Ji Sun Kim, Kyoung-Sae Na, Sang-Woo Hahn, Seung-Hwan Lee; Psychiatry Investig. 2020;17(8):796-803. Published online August 6, 2020; DOI: https://doi.org/10.30773/pi.2020.0017
Web of Science 2 Crossref 3; Full text PubReader ePub PDF

Pharmacological and Neuromodulatory Treatments for Panic Disorder: Clinical Trials from 2010 to 2018: Morena M. Zugliani, Mariana C. Cabo, Antonio E. Nardi, Giampaolo Perna, Rafael C. Freire; Psychiatry Investig. 2019;16(1):50-58. Published online January 25, 2019; DOI: https://doi.org/10.30773/pi.2018.12.21.1
Web of Science 17 Crossref 15; Full text PubReader ePub PDF

Serum N-Desmethylcitalopram Concentrations are Associated with the Clinical Response to Citalopram of Patients with Major Depression: Gul Ozbey, Berna Yucel, Nurdan Eren Bodur, Serap Erdogan Taycan, Tayyibe Arslan, Nazan Cerit, Nevzat Yuksel, Ismail Cuneyt Guzey, Canan Uluoglu; Psychiatry Investig. 2018;15(3):313-319. Published online February 22, 2018; DOI: https://doi.org/10.30773/pi.2017.05.22
Crossref 7; Full text PubReader ePub PDF

Times to Discontinue Antidepressants Over 6 Months in Patients with Major Depressive Disorder: Woo-Young Jung, Sae-Heon Jang, Sung-Gon Kim, Young-Myo Jae, Bo-Geum Kong, Ho-Chan Kim, Byeong-Moo Choe, Jeong-Gee Kim, Choong-Rak Kim; Psychiatry Investig. 2016;13(4):440-446. Published online July 25, 2016; DOI: https://doi.org/10.4306/pi.2016.13.4.440
Crossref 12; Full text PubReader PDF

Design and Methodology for the Korean Observational and Escitalopram Treatment Studies of Depression in Acute Coronary Syndrome: K-DEPACS and EsDEPACS: Jae-Min Kim, Kyung-Yeol Bae, Hee-Ju Kang, Sung-Wan Kim, Il-Seon Shin, Young-Joon Hong, Ju-Han Kim, Hee-Young Shin, YoungKeun Ahn, Jong-Keun Kim, Myung-Ho Jeong, Jin-Sang Yoon; Psychiatry Investig. 2014;11(1):89-94. Published online January 21, 2014; DOI: https://doi.org/10.4306/pi.2014.11.1.89
Crossref 39; Full text PubReader PDF

CYP2D6 P34S Polymorphism and Outcomes of Escitalopram Treatment in Koreans with Major Depression: Kyu-Man Han, Hun Soo Chang, In-Kwang Choi, Byung-Joo Ham, Min-Soo Lee; Psychiatry Investig. 2013;10(3):286-293. Published online September 16, 2013; DOI: https://doi.org/10.4306/pi.2013.10.3.286
Crossref 14; Full text PubReader PDF

A Case of Galactorrhea Associated with Excitalopram: Se-Hoon Shim, Yeon-Jeong Lee, Eun-Chan Lee; Psychiatry Investig. 2009;6(3):230-232. Published online July 15, 2009; DOI: https://doi.org/10.4306/pi.2009.6.3.230
Crossref 12; Full text PubReader PDF

A Case of Pulmonary Embolism Associated with Escitalopram: Yong Woo Kim;Sang Hyuk Lee;Tae Kyou Choi;Ki Hwan Yook; and Shin Young Suh; Psychiatry Investig. 2007;4(1):52-4.; PDF

Increased Low-Density Lipoprotein Cholesterol Levels after 6 Months of Citalopram Treatment in Patients with Panic Disorder: Hyun-Wook Cho; and Bum-Hee Yu; Psychiatry Investig. 2007;4(1):38-40.; PDF

Search